Pralidoxime Chloride (Meridian Medical Technologies, Inc.)


Welcome to the PulseAid listing for the Pralidoxime Chloride drug offered from Meridian Medical Technologies, Inc.. This Cholinesterase Reactivator [EPC],Cholinesterase Reactivators [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Meridian Medical Technologies, Inc.
NON-PROPRIETARY NAME: Pralidoxime Chloride
SUBSTANCE NAME: PRALIDOXIME CHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cholinesterase Reactivator [EPC],Cholinesterase Reactivators [MoA]
ROUTE: INTRAMUSCULAR
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1983-04-26
END MARKETING DATE: 0000-00-00


Pralidoxime Chloride HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPralidoxime Chloride from Meridian Medical Technologies, Inc.
LABELER NAME: Meridian Medical Technologies, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 600(mg/2mL)
START MARKETING DATE: 1983-04-26
END MARKETING DATE: 0000-00-00
PRODUCT ID: 11704-251_3a03ec88-5282-4da2-a5b8-f3320a964e2c
PRODUCT NDC: 11704-251
APPLICATION NUMBER: NDA018986

Other PRALIDOXIME CHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Baxter Healthcare CorporationProtopam Chloride
Meridian Medical Technologies, Inc.Pralidoxime Chloride